FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

ROCHE ORAL FLUID AMPHETAMINE, ROCHE ORAL FLUID DAT QUAL CAL B, ROCHE ORAL FLUID DAT CONTROL SET B, AND ROCHE ORAL FLUID

K Number: K110446 · Decision May 3, 2011
Classifications
1
FEI Numbers
96
Registration Numbers
96
Same Product Code
224
Applicant Total
183
Review Days
76

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ROCHE ORAL FLUID AMPHETAMINE, ROCHE ORAL FLUID DAT QUAL CAL B, ROCHE ORAL FLUID DAT CONTROL SET B, AND ROCHE ORAL FLUID
K Number
K110446
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3100
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics
Date Received
February 16, 2011
Decision Date
May 3, 2011
Product Code
DKZ
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DKZ Enzyme Immunoassay, Amphetamine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DKZ), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics

K Number Device Name
K252323 cobas pulse blood glucose monitoring system
K252280 Elecsys Anti-SARS-CoV-2 S
K260048 Elecsys Anti-HAV IgM
K260049 Elecsys Anti-HBc IgM
K260046 Elecsys Anti-HBc II
K260026 Tina-quant Cardiac high sensitivity CRP III
K253490 Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions
K253491 ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions
K253839 Elecsys Anti-SARS-CoV-2
K253188 CoaguChek XS Plus System
Search all 183 clearances from Roche Diagnostics →